{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:24Z","timestamp":1786987044671,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.clinthera.2008.01.022","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T11:11:31Z","timestamp":1208430691000},"page":"326-337","source":"Crossref","is-referenced-by-count":24,"title":["Practical management of cutaneous reactions to the methylphenidate transdermal system: Recommendations from a dermatology expert panel consensus meeting"],"prefix":"10.1016","volume":"30","author":[{"given":"Erin M.","family":"Warshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Zirwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.01.022_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)","year":"2000"},{"key":"10.1016\/j.clinthera.2008.01.022_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1542\/pir.9-9-287","article-title":"Attention deficits in adolescence: Description, evaluation, and management","volume":"9","author":"Coleman","year":"1988","journal-title":"Pediatr Rev"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.01.022_bib3","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1542\/peds.2006-2089O","article-title":"National estimates and factors associated with medication treatment for childhood attention-deficit\/hyperactivity disorder","volume":"119","author":"Visser","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2008.01.022_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.292.5.619","article-title":"Attention-deficit\/hyperactivity disorder in adults","volume":"292","author":"Wilens","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.01.022_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpsyc.56.12.1088","article-title":"Moderators and mediators of treatment response for children with attention-deficit\/hyperactivity disorder: The Multimodal Treatment Study of children with attention-deficit\/hyperactivity disorder","volume":"56","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2008.01.022_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.chi.0000128791.10014.ac","article-title":"Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment","volume":"43","author":"Abikoff","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2008.01.022_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2165\/00023210-200418140-00005","article-title":"New formulations of stimulants for attention-deficit hyperactivity disorder: Therapeutic potential","volume":"18","author":"Connor","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2008.01.022_bib8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2008.01.022_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0733-8635(05)70011-5","article-title":"Transdermal drug delivery. Clinical aspects","volume":"16","author":"Kalia","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clinthera.2008.01.022_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2006.03.009","article-title":"Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute","volume":"64","author":"Wokovich","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.clinthera.2008.01.022_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2310\/6620.2006.05051","article-title":"Cutaneous reactions to transdermal therapeutic systems","volume":"17","author":"Musel","year":"2006","journal-title":"Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib12","author":"Wilkosz"},{"key":"10.1016\/j.clinthera.2008.01.022_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)63383-2","article-title":"Contact dermatitis","volume":"78","author":"Beltrani","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib15","first-page":"4","article-title":"Prevention of irritant contact dermatitis","volume":"12","author":"L\u00f6ffler","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0738-081X(95)00103-M","article-title":"Detergent and skin irritation","volume":"14","author":"Effendy","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0536.1989.tb04712.x","article-title":"Allergic contact dermatitis from transdermal nitroglycerin","volume":"21","author":"Carmichael","year":"1989","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib18","first-page":"709","article-title":"Clinical evaluation of the contact sensitization potential ofa transdermal nicotine system (Nicoderm) [published correction appears in J Fam Pract. 1992;35:138]","volume":"34","author":"Jordan","year":"1992","journal-title":"J Fam Pract"},{"key":"10.1016\/j.clinthera.2008.01.022_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tiv.2003.09.009","article-title":"In vitro skin irritation: Facts and future. State of the art review of mechanisms and models","volume":"18","author":"Welss","year":"2004","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.clinthera.2008.01.022_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0738-081X(98)00047-9","article-title":"Adverse skin reactions to the nicotine transdermal system","volume":"16","author":"Wolf","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0536.1995.tb00472.x","article-title":"Effect of occlusion on human skin","volume":"33","author":"Matsumura","year":"1995","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1600-0536.2001.044004201.x","article-title":"Skin occlusion and irritant and allergic contact dermatitis: An overview","volume":"44","author":"Zhai","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0536.1997.tb00191.x","article-title":"Conformability and irritancy of adhesive tapes on the skin","volume":"37","author":"Tokumura","year":"1997","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0536.1989.tb04754.x","article-title":"Post-application occlusion substantially increases the irritant response of the skin to repeated short-term sodium lauryl sulfate (SLS) exposure","volume":"21","author":"Van der Valk","year":"1989","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0536.1999.tb06990.x","article-title":"How irritant is water? An overview","volume":"41","author":"Tsai","year":"1999","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib26","series-title":"Occupational Skin Disease","first-page":"1","article-title":"Contact dermatitis due to irritation: Clinical appearance, predisposing factors and therapy","author":"Wigger-Alberti","year":"1999"},{"key":"10.1016\/j.clinthera.2008.01.022_bib27","series-title":"Fisher's Contact Dermatitis","first-page":"1","article-title":"The pathogenesis of allergic contact hypersensitivity","author":"Rietschel","year":"2001"},{"key":"10.1016\/j.clinthera.2008.01.022_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1525-1470.2005.22100.x","article-title":"Contact sensitization in 1094 children undergoing patch testing over a 7-year period","volume":"22","author":"Seidenari","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.det.2007.06.002","article-title":"Contact dermatitis","volume":"25","author":"Fyhrquist-Vanni","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clinthera.2008.01.022_bib30","series-title":"Conn's Current Therapy","first-page":"830","article-title":"Contact dermatitis","author":"Warshaw","year":"2000"},{"key":"10.1016\/j.clinthera.2008.01.022_bib31","first-page":"38","article-title":"Allergic contact dermatitis","volume":"87","author":"Zeller","year":"2004","journal-title":"Minn Med"},{"key":"10.1016\/j.clinthera.2008.01.022_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1742-1241.1996.tb09603.x","article-title":"Allergic reactions to local glyceryl trinitrate administration","volume":"50","author":"Kounis","year":"1996","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.clinthera.2008.01.022_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0536.1991.tb01850.x","article-title":"Adverse skin reactions to nicotine in a transdermal therapeutic system","volume":"25","author":"Bircher","year":"1991","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0536.1993.tb03500.x","article-title":"Allergic contact dermatitis from transdermal nicotine systems","volume":"29","author":"Vincenzi","year":"1993","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.iac.2004.01.005","article-title":"Physical urticaria","volume":"24","author":"Dice","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.clinthera.2008.01.022_bib36","series-title":"Fisher's Contact Dermatitis","first-page":"89","article-title":"Systemic contact-type dermatitis","author":"Rietschel","year":"2001"},{"key":"10.1016\/j.clinthera.2008.01.022_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1378\/chest.93.5.941","article-title":"Efficacy and safety of two-year therapy with transdermal clo-nidine for essential hypertension","volume":"93","author":"Horning","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2008.01.022_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1034\/j.1600-0536.2002.460513.x","article-title":"Generalized allergic contact dermatitis from nitroglycerin in a transdermal therapeutic system","volume":"46","author":"P\u00e9rez-Calder\u00f3n","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0536.1992.tb00873.x","article-title":"Allergic contact dermatitis from nitroglycerin and estradiol transdermal therapeutic systems","volume":"26","author":"Torres","year":"1992","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0002-8703(84)90488-5","article-title":"Allergic contact dermatitis secondary to transdermal nitroglycerin","volume":"108","author":"Rosenfeld","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2008.01.022_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0536.1989.tb03087.x","article-title":"A review of contact dermatitis associated with transdermal therapeutic systems","volume":"20","author":"Holdiness","year":"1989","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib42","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1001\/jama.1991.03470220049025","article-title":"Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials","volume":"266","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.01.022_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0190-9622(90)70113-V","article-title":"Adverse dermatologic reactions to transdermal drug delivery systems","volume":"22","author":"Hogan","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0536.1987.tb02607.x","article-title":"Oral substitution in patients sensitized by transdermal clonidine treatment","volume":"16","author":"Maibach","year":"1987","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0536.1993.tb03545.x","article-title":"Contact allergy to nicotine from a nicotine patch","volume":"29","author":"F\u00e4rm","year":"1993","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib46","first-page":"1064","article-title":"Allergic reaction to methylphenidate","volume":"106","author":"Rothschild","year":"1972","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.clinthera.2008.01.022_bib47","first-page":"115","article-title":"Hypersensitivity to methylphenidate and dextroam-phetamine: A report of two cases","volume":"59","author":"Sverd","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2008.01.022_bib48","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1177\/106002809202601223","article-title":"Fixed drug eruption caused by acetaminophen","volume":"26","author":"Cohen","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2008.01.022_bib49","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/cap.2005.15.703","article-title":"Successful desensitization of methylphenidate-induced rash","volume":"15","author":"Confino-Cohen","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib50","first-page":"402","article-title":"Exfoliative dermatitis after medication with methylphenidate HC1 (ritalin)","volume":"26","author":"Weil","year":"1968","journal-title":"Ann Allergy"},{"key":"10.1016\/j.clinthera.2008.01.022_bib51","first-page":"154","article-title":"Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides","volume":"63","author":"Polster","year":"1999","journal-title":"Cutis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib52","series-title":"Daytrana [package insert]","year":"2007"},{"key":"10.1016\/j.clinthera.2008.01.022_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1087054705284089","article-title":"A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD","volume":"9","author":"McGough","year":"2006","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clinthera.2008.01.022_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4088\/JCP.v69n0120","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit hyper-activity disorder","volume":"69","author":"Findling","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2008.01.022_bib55","unstructured":"Wilens TE, Boellner SW, L\u00e9pez FA, et al. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. In press."},{"key":"10.1016\/j.clinthera.2008.01.022_bib56","series-title":"Presented at: 53rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry","article-title":"Efficacy of transdermal methylphenidate in subjects converted from oral methylphenidate","author":"Rugino","year":"2006"},{"key":"10.1016\/j.clinthera.2008.01.022_bib57","series-title":"Presented at: Annual Meeting of the American Psychiatric Association","article-title":"Skin response to methylphenidate transdermal system in pediatric subjects","author":"Lopez","year":"2006"},{"key":"10.1016\/j.clinthera.2008.01.022_bib58","series-title":"A Phase I study to assess the pharmacokinetics of methylphenidate transdermal system (MTS) vs. Concerta in pediatric patients aged 6-12 with attention-deficit\/hyperactivity disorder (ADHD) [protocol SPD485-101]","author":"Boellner","year":"2004"},{"key":"10.1016\/j.clinthera.2008.01.022_bib59","series-title":"A Phase I study to assess the relative bioavailability and pharmacokinetics of methylphenidate transdermal system (MTS) vs. Concerta in pediatric patients aged 6-12 with attention-deficit\/hyperactivity disorder (ADHD) [protocol SPD485-102]","author":"Boellner","year":"2005"},{"key":"10.1016\/j.clinthera.2008.01.022_bib60","author":"Wigal","year":"2005"},{"key":"10.1016\/j.clinthera.2008.01.022_bib61","author":"Findling","year":"2005"},{"key":"10.1016\/j.clinthera.2008.01.022_bib62","series-title":"A Phase III, multi-center, open-label study of methylphenidate transdermal system (MTS) in pediatric patients aged 6\u201312 with attention-deficit\/hyperactivity disorder (ADHD) [protocol SPD485\u2013303]","author":"Findling","year":"2007"},{"key":"10.1016\/j.clinthera.2008.01.022_bib63","author":"Wilens","year":"2006"},{"key":"10.1016\/j.clinthera.2008.01.022_bib64","series-title":"A prospective, open-label, multi-center study evaluating the safety and tolerability of methylphenidate transdermal system (MTS) in children aged 6\u201312 previously treated with extended-release methylphenidate product [protocol SPD485\u2013305]","author":"Arnold","year":"2006"},{"key":"10.1016\/j.clinthera.2008.01.022_bib65","series-title":"Shire overview of dermatological responses","year":"2006"},{"key":"10.1016\/j.clinthera.2008.01.022_bib66","series-title":"A Phase IV, Multi-center, open-label study of Daytrana (methylphenidate transdermal system [MTS]) to characterize the dermal reactions in pediatric patients aged 6\u201312 with attention deficit\/hyperactivity disorder (ADHD) [protocol SPD485\u2013411]","author":"Wilens","year":"2007"},{"key":"10.1016\/j.clinthera.2008.01.022_bib67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1600-0536.2002.470501.x","article-title":"Skin protection programmes","volume":"47","author":"Agner","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib68","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1542\/peds.2007-0542","article-title":"Treating attention-deficit\/hyperactivity disorder with a stimulant transdermal patch: The clinical art","volume":"120","author":"Arnold","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2008.01.022_bib69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0536.1995.tb00470.x","article-title":"Surfactants and experimental irritant contact dermatitis","volume":"33","author":"Effendy","year":"1995","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2133.2007.07944.x","article-title":"How irritant is alcohol?","volume":"157","author":"L\u00f6ffler","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinthera.2008.01.022_bib71","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-0029(19970501)37:3<193::AID-JEMT4>3.0.CO;2-P","article-title":"Ultrastructure of the epidermal barrier after irritation","volume":"37","author":"Fartasch","year":"1997","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.clinthera.2008.01.022_bib72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1034\/j.1600-0536.2001.450505.x","article-title":"Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: A multicenter study","volume":"45","author":"Berardesca","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib73","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1034\/j.1600-0536.2001.044006337.x","article-title":"Beneficial effects of a skin tolerance-tested moisturizing cream on the barrier function in experimentally-elicited irritant and allergic contact dermatitis","volume":"44","author":"De Pa\u00e9pe","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clinthera.2008.01.022_bib74","first-page":"1425","article-title":"Treatment options for pharmacotherapy","volume":"21","author":"McGriff","year":"2001","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clinthera.2008.01.022_bib75","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.mop.0000236387.56709.6d","article-title":"Allergic contact dermatitis in children","volume":"18","author":"Militello","year":"2006","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.clinthera.2008.01.022_bib76","first-page":"3","article-title":"Allergic contact dermatitis in children: A practical approach to management","volume":"7","author":"Bruckner","year":"2002","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.clinthera.2008.01.022_bib77","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1034\/j.1600-0536.2000.043006317.x","article-title":"An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis","volume":"43","author":"Levin","year":"2000","journal-title":"Contact Dermatitis"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T16:11:40Z","timestamp":1684339900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0149291808000702"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.01.022","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}